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Te impact of a nurse practitioner-led symptom clinic on emergency department use in cancer patients E mergency department (ED) use and hospitalization across the continuum of cancer treatment are common and distressing issues for patients and their families. Use of these services is recognized as an indicator of poor quality end-oflife care, but studies have demonstrated frequent use of them in patients with advanced cancer and particularly in those who are close to the end of life. [1] [2] [3] Tere is growing evidence that more than 50% of ED visits are secondary to cancer symptoms and that nearly 23% of visits could be avoided. 4, 5 Early identifcation of these patients and aggressive outpatient symptom management may reduce ED use and hospitalization. Tis improved quality of care could also have a positive impact on the high cost of end-of-life cancer care. Diferent models of care have been explored to provide outpatient supportive treatment to cancer patients, including nurse practitioner (NP)-driven symptom management clinics.
In this study, we explored the characteristics of high users of emergency department services and the impact of an NP-led, physician-supervised, symptom management clinic on the total frequency of emergency department visits.
Methods
We conducted a retrospective review of ED encounters to improve quality of care and quantify the frequency of ED use by cancer patients at a community cancer institute. Te review period was from October 1, 2012 to September 30, 2013, and a total of 425 patient charts were audited to evaluate ED use by patients who were actively receiving chemotherapy, radiation therapy, or combination therapy. Chart abstractions were completed for each encounter to determine if the patient had received cancer treatment within 30 days of the ED visit. Only patients who were receiving active treatment were included in the quality review. Metrics for each patient were collected through review of history, physical, and provider ofce notes in the electronic medical record. Patient disease site, stage, and treatment modality were collected for each encounter. Additional data about the ED encounter were collected from the emergency department provider notes and progress notes associated with the admission. Data points collected for each ED encounter included: contact with an oncology provider prior to the ED encounter, chief complaint/symptom, admission disposition, and oncology provider visits completed prior to the ED encounter.
From this data we sought to quantify ED use in our patient population both before and after initiation of an NP-led, physician-supervised symptom management clinic. Te clinic exists within a large cancer institute afliated with a community hospital. Tere are 8 dedicated medical oncologists at the institute. Te clinic was stafed by 1 NP with dedicated slots for symptom management 5 days a week during business hours. Physicians saw their own patients urgently when the NP was not present. Referrals to the clinic were made either by the managing physician or based on needs identifed during patient calls to the nurse triage service. Te ED data were frst analyzed to describe the use of ED care by oncology patients receiving active treatments for a 12-month period. Te data on ED use were then divided into 2 groups. Tose encounters that occurred in the 6 months immediately before the initiation of the symptom management clinic (October 2012-March 2013), were compared with those in 6 months after the launch of the clinic (April 2013-September 2013).
Results
A total of 425 ED encounters by patients under treatment were identifed during a period of 12 months. Of those, 195 encounters occurred in the 6 months before the initiation of the symptom management clinic, and 230 encounters occurred in the 6 months after its initiation. Tere was a 17.9% increase in ED use during the 6 months after initiation of a symptom management clinic (Figure 1 ).
Before and after initiation of the symptom management clinic, the most common disease site was lung (22.1% of study population), with a total of 94 ED encounters during the 12 months, followed by breast (13.2% of total population), with a total of 56 encounters (Table) . Colon cancer and multiple myeloma also ranked in the top 5 sites both before and after symptom management, as well as collectively. Patients with stage IV disease were the highest users of ED services (36.4% of the total population) both before and after initiation of the symptom management clinic. Te majority of patients (95.8%) were receiving chemotherapy alone (Table) . Of the remaining patients, 2.3% were receiving a combination of radiation and chemotherapy, and 1.9% were receiving radiation therapy alone. Tis did not difer signifcantly in the before and after symptom management populations.
Pain was the most common complaint among the patients who used the emergency department. A total of 81 patients (19.1%) went to the ED because of pain, followed by 67 patients (15.8%) for shortness of breath, 54 (12.7%) for fever, 54 (12.7%) for weakness, and 37 (8.7%) for nausea, vomiting, and diarrhea. Before the symptom management clinic, the top 5 oncology-related symptoms reported in the ED were shortness of breath (36, 18.5%), pain (29, 14.9%), fever (23, 11.8%), weakness (23, 11.8%), and chest pain (18, 9.2%). In the 6 months after the clinic was initiated, the symptoms were pain (52, 22.6%), shortness of breath (31, 13.5%), fever (31, 13.5%), weakness (31, 13.5%), and nausea, vomiting, and diarrhea (21, 9.1%).
Most patients did not contact a provider (including nurse navigators or nursing triage phone lines) before their ED encounter. In all, only 25.6% of the total population did so, with 23.1% of patients having a phone call documented before their ED visit in the 6-month period before the symptom management clinic. Tere was a slight increase in contact with a provider to 27.8% in the 6-month period after the clinic was initiated, but the increase was not statistically signifcant.
Disposition after the ED visit was reviewed for each encounter. Of the total ED encounters, 232 patients (54.6%) were admitted to an inpatient unit, 16 (3.8%) were admitted under observation status, and the remaining 177 patients (41.6%) were discharged directly from the ED. www.jcso-online.com
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Similar disposition percentages occurred before and after the symptom management clinic (Table) .
Time of day and day of week of the ED encounters were determined. Figure 2 displays the distribution of total emergency department encounters across 24 hours, across the 3 nursing shifts, and the number of ED visits by day of week.
Most ED visits occurred on a Monday (total of 75 patient encounters), with Saturday and Sunday having the second and third highest number of visits (69 for Saturday encounters and 65 for Sunday encounters, respectively). Te peak time of day for ED use was 8 pm, and when stratifed across nursing shifts, most patients (212) were seen during the evening shift (3 pm-11 pm), with the second-highest period of use occurring during the day shift (7 am-3 pm) and the lowest level of use occurring during the night shift (11 pm-7 am). Tis fnding was consistent for both before and after initiation of the symptom management clinic. As part of the quality review, each ED encounter was reviewed to establish if the patient had completed an ofce visit with an oncology provider, and if so, how close the visit had been to the ED encounter. Te majority of patients reviewed had had an ofce visit with an oncology provider within 30 days of the ED encounter (84.6% before clinic initiation and 84.8% after; Figure 3 ). However, after initiation of the symptom management clinic, only 20 of the 195 patients seen by an oncology provider before the ED encounter had been seen in the symptom management clinic by the nurse practitioner. Specifcally, during the second 6-month review period, 415 patients were seen by the NP for acute symptom management. Of those patients, the aforementioned 20 were seen by the NP before to an ED visit. Tat means possibly 395 patients (95%) who had been seen by the NP had avoided hospitalization.
Discussion
In 2011, the Institute of Medicine issued a report advising that advanced-practice registered nurses (APRNs) should be partnering with other health care clinicians to practice to the full extent of their training. 6 APRNs have played an increasingly important role in oncology by both managing patients with cancer and providing palliative care and symptom management. 7 In the United States, there is 1 oncologist for every 141 newly diagnosed cancer patients, but there is only 1 palliative care physician for every 1,200 patients with a serious illness. 8 Tus, using APRNs in the outpatient oncology setting for urgent symptom management support may be a way of avoiding ED visits for symptom treatment. Several studies have explored the role of APRN-led supportive care clinics embedded in oncology practices and have demonstrated beneft in providing urgent access for symptom management and in some cases, reducing rates of hospitalization. [9] [10] [11] Our study fndings are supported by other fndings showing that the highest level of ED and supportive clinic use is in advanced cancer patients, most commonly in those with lung or breast cancer who are receiving cytotoxic chemotherapy. 5, 9, [12] [13] [14] [15] In addition, the uncontrolled symptoms of shortness of breath, pain, weakness, fever, nausea, vomiting, and diarrhea which commonly led to ED visits in our patient population were consistently the top sources of distress in other published studies 5, 9, [12] [13] [14] Of those, pain, nausea, and vomiting have been identifed in 2 studies as potentially avoidable reasons for hospitalization. 4, 5 Despite instituting an NP-stafed symptom management clinic to manage the aforementioned symptoms, we retrospectively found a 17.9% increase in ED use. Tis suggests that increased access to urgent care visits alone is not enough to prevent avoidable hospitalizations.
Most of the patients in our study who presented to the ED did not contact their oncology provider before or after the institution of the symptom management clinic. Although most of the patients had an ofce visit with their provider within 30 days before ED presentation, fewer than 10% of the patients had subsequent visits with the NP. In addition, 41% of the patients who presented to the ED were treated and discharged from the ED, which suggests that many of these could have been managed Breakdown of patients before and after symptom management clinic initiation that were seen by an oncology provider before their emergency department encounter.
www.jcso-online.com In one study, a weekly NP-managed symptom management clinic was instituted for patients who were receiving intensive chemoradiotherapy for oropharyngeal cancer.
Although that doubled the number of visits to the outpatient clinic, the hospitalization rate was cut by more than half. 11 Tis suggests that a more structured visit schedule is more efective than as-needed visits for patients with a high symptom burden. Other studies have emphasized the benefts of the symptom management clinic through patient education before starting chemotherapy and education reinforcing this during chemotherapy. 9 We have incorporated this strategy in our approach in an efort to optimize the services of our own clinic.
We identifed a high-risk population of patients who are high users of the ED. NP-stafed symptom management clinics could aggressively manage the symptom burden of these patients and possibly reduce ED visits, as other fndings have demonstrated. Although we did not directly demonstrate that, we have shown that the majority of patients seen acutely by an NP potentially avoid hospitalization, and we identifed weaknesses of care delivery in our clinic that could be optimized. Tese include scheduling regular visits with the NP for symptomatic patients until control or resolution of symptoms and educating our patients on the availability of this clinic. In addition, as Monday, Saturday, and Sunday were the peak days for ED use, timing-scheduled NP visits for our at-risk population to occur later in the week may reduce the number of visits to the ED when our cancer institute is closed. Finally, consideration of extended access to our infusion room facilities may reduce the use of the ED during evening hours, another peak use time. Future work should include optimizing the role and practice of NP-driven symptom management clinics to reduce ED use and increase quality of life for cancer patients.
